A jury in Philadelphia has returned a $3 million against Johnson & Johnson, maker of the anti-epilepsy drug Topamax. The family that filed suit claimed their child was born with a cleft lip after her mother took Topamax to treat migraines during her pregnancy. The jury found that the company failed to warn the woman of the risk of birth defects when taken during pregnancy. Studies have shown that Topamax increases the incidents of cleft lips and cleft palates in newborns when taken by mothers during pregnancy. More than 130 additional Topamax cases are pending as a part of the Philadelphia court system's mass tort program.
[1] Orzeck, K. "J&J Unit Hit With $3M Jury Verdict in Topamax Row," Law360 (March 7, 2014).
[1] Orzeck, K. "J&J Unit Hit With $3M Jury Verdict in Topamax Row," Law360 (March 7, 2014).
RSS Feed
